Anmar Alrabadi, MD
Nephrology · South Charleston, WVNPI 1730314998
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $833 of the $937 with a category attached, or 88.9%. It is spread thinly across 13 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $341 and has fallen 69.9% since, to $103 in 2025. That places this record below the midpoint for nephrology clinicians in WV, where the typical reported total is $740.
Across 45 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$210
- Calliditas Therapeutics US Inc.$140
- Otsuka America Pharmaceutical, Inc.$129
- Fresenius USA Marketing, Inc.$121
- Bayer$86
- Vifor Pharma, Inc.$70
- plus $180 from 7 others
What the payments were for
- Food & beverage$83389%
- Education$10411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $210 |
| Calliditas Therapeutics US Inc. | 6 | $140 |
| Otsuka America Pharmaceutical, Inc. | 4 | $129 |
| Fresenius USA Marketing, Inc. | 5 | $121 |
| Bayer | 5 | $86 |
| Vifor Pharma, Inc. | 4 | $70 |
| Akebia Therapeutics Inc | 2 | $39 |
| Travere Therapeutics, Inc. | 3 | $31 |
| Ardelyx, Inc. | 1 | $30 |
| Mallinckrodt Enterprises LLC | 1 | $27 |
| Genentech USA, Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $17 |
| Amgen | 1 | $13 |
How this compares
$937 in reported general payments places this provider in the 50th percentile of 55 nephrology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 26 | $108,084 |
| AuryxiaFerric Citrate | 23 | $48,973 |
| KerendiaFinerenone | 36 | $31,328 |
| VeltassaPatiromer Calcium Sorbitex | 11 | $16,323 |
| Sevelamer Carbonate | 44 | $10,337 |
| JanuviaSitagliptin Phosphate | 12 | $6,476 |
| Bumetanide | 106 | $3,570 |
| Cinacalcet Hcl | 27 | $3,546 |
| Gentamicin Sulfate | 16 | $591 |
| Losartan Potassium | 52 | $572 |
| Potassium Chloride | 27 | $494 |
| Hydralazine Hcl | 32 | $420 |
| Lisinopril | 58 | $398 |
| Calcitriol | 38 | $291 |
| Carvedilol | 56 | $284 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Fresenius USA Marketing, Inc.Velphoro | $121 | $108,08426 claims |
| Akebia Therapeutics IncAuryxia | $39 | $48,97323 claims |
| BayerKerendia | $86 | $31,32836 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 55 nephrology providers in West Virginia.
Other nephrology in South Charleston
- Julian EspirituSouth Charleston$215K
- Julie HaddySouth Charleston$3K
- Agura AfiariSouth Charleston$177
- Abdul ZanabliS Charleston$31K
- Murad KheetanHuntington$25K
- Arijit ChakravartyMorgantown$19K
- Asif RahmanCharleston$8K
- Mirza HamiraniVienna$8K
- Michael CollinsHuntington$7K
- Khan ShabihCharleston$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.